CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-15 | Marquet Magda Director | Sale | −1,710 | $48.85 | $84K | 9,930 |
| 2026-01-15 | Marquet Magda Director | Option exercise · Stock Option (right to buy) | −11,000 | 0 | ||
| 2026-01-08 | Lizzul Paul F. Chief Medical Officer | Sale | −3,650 | $44.71 | $163K | 42,088 |
| 2026-01-08 | Faga Daniel President, CEO | Sale | −14,281 | $44.71 | $639K | 479,344 |
| 2026-01-08 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −2,515 | $44.71 | $112K | 21,852 |
| 2026-01-08 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | −2,210 | $44.71 | $99K | 12,835 |
| 2026-01-07 | Lizzul Paul F. Chief Medical Officer | Option exercise | +8,525 | 45,738 | ||
| 2026-01-07 | Lizzul Paul F. Chief Medical Officer | Option exercise · Restricted Stock Unit | −8,525 | 25,575 | ||
| 2026-01-07 | Faga Daniel President, CEO | Option exercise | +26,838 | 493,625 | ||
| 2026-01-07 | Faga Daniel President, CEO | Option exercise · Restricted Stock Unit | −26,838 | 80,512 | ||
| 2026-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise | +6,700 | 24,367 | ||
| 2026-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −6,700 | 20,100 | ||
| 2026-01-07 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise | +5,888 | 15,045 | ||
| 2026-01-07 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit | −5,888 | 17,662 | ||
| 2026-01-07 | Lizzul Paul F. Chief Medical Officer | Sale | −2,235 | $45.11 | $101K | 37,213 |
| 2026-01-07 | Faga Daniel President, CEO | Sale | −9,202 | $45.11 | $415K | 466,787 |
| 2026-01-07 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −1,908 | $45.11 | $86K | 17,667 |
| 2026-01-07 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | −2,017 | $45.11 | $91K | 16,779 |
| 2026-01-07 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | −5,281 | $45.38 | $240K | 11,498 |
| 2026-01-07 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | −1,841 | $46.13 | $85K | 9,657 |
Page 6 of 17 · 339 trades